Psoriasis is a chronic, immune‑mediated inflammatory skin disease, affecting approximately 2–3% of the global population, with significant variation across regions and ethnicities. It commonly manifests as erythematous, scaly plaques, and in about 20–30% of cases, progresses to psoriatic arthritis (PsA). Although treatment options, including topical agents, phototherapy, systemic drugs, and biologics, have expanded, effective management remains challenging due to adverse effects, variable patient responses, treatment resistance, long-term safety concerns, and high costs.
These realities underscore the need for personalized, multimodal therapeutic strategies in the management of psoriasis. Take this brief quiz to review key clinical insights on psoriasis. ##References## International Journal of Molecular Sciences, International Journal of Research in Dermatology, Allergies, Journal of…
